Vasa is a conserved RNA-helicase found in the germ lines of all metazoans tested. Whereas Vasa presence is often indicated as a metric for germline determination in animals, it is also expressed in stem cells of diverse origin. Recent research suggests, however, that Vasa has a much broader function, including a significant role in cell cycle regulation. Results herein indicate that Vasa is utilized widely, and often induced transiently, during development in diverse somatic cells and adult precursor tissues. We identified that Vasa in the sea urchin is essential for: (1) general mRNA translation during embryogenesis, (2) developmental re-programming upon manipulations to the embryo and (3) larval wound healing. We also learned that Vasa interacted with mRNAs in the perinuclear area and at the spindle in an Importin-dependent manner during cell cycle progression. These results suggest that, when present, Vasa functions are essential to contributing to developmental regulation.
Vasa is expressed in germ cells of all metazoans tested (Hay et al., 1988; Lasko and Ashburner, 1988, 1990; Raz, 2000; Yajima and Wessel, 2011a), yet recent studies demonstrate that Vasa has much broader functional roles in stem cells, cancer cells and in somatic embryonic cells (Rebscher et al., 2007; Janic et al., 2010; Yajima and Wessel, 2011b,c; Lasko, 2013; Juliano and Wessel, 2010; Paz-Gómez et al., 2014; Schwager et al., 2014). However, its function in these diverse cells remains unclear, especially when considering different demands between the germ line and somatic lineages. We previously reported in the sea urchin embryo that Vasa localized to the spindle in early blastomeres during M phase and functioned in cell cycle progression during embryogenesis, in addition to its roles in the germ line (Yajima and Wessel, 2011b,c). A similar cell cycle function was reported in Drosophila germline stem cells (Pek and Kai, 2011), and these results cast new light onto Vasa as a regulator of cellular potency in proliferative cells.
Echinoderms are a sister group to chordates and are known for their strong regenerative abilities. Representatives of each of the major groups of echinoderms can regenerate entire body segments as an adult, complete with skeletons, neurons and gravid gonads (e.g. Goss, 1969; Emson and Wilkie, 1980; Mashanov and García-Arrarás, 2011). Echinoderm larvae can even produce a functional larval clone derived by budding from the original larval body (Bosch et al., 1989; Eaves and Palmer, 2003). Embryos from this phylum are well known for marked regulative development; many cells maintain ‘multipotency’ and change fates in response to changes in neighbouring cells (Horstadius, 1950,1973; Ransick and Davidson, 1993; Dubois and Ameye, 2001), including the germ line (Goss, 1969; Emson and Wilkie, 1980; Eaves and Palmer, 2003; Vaughn and Strathmann, 2008; Ransick and Davidson, 1993).
Sea urchins have only one vasa gene (Voronina et al., 2008). The authenticity of this gene as vasa was previously documented and it is highly conserved, especially in the DEAD box and C-terminal domains (Juliano et al., 2006; Juliano and Wessel, 2009; Gustafson and Wessel, 2010a,b). During early sea urchin development, vasa mRNA is uniformly distributed throughout the early embryo, and after gastrulation it becomes enriched in the small micromere lineage. Vasa protein is also uniformly distributed until the 8-cell stage, but becomes enriched in the micromeres at the 16-cell stage and then in the small micromeres at the 32-cell stage (Voronina et al., 2008). Although the vasa mRNA and the Vasa protein are both concentrated in the small micromere lineage, they are both detectable throughout the embryo and larva. In this report, we reveal broad functional contributions and unique regulatory mechanisms used by Vasa outside of the germ line that are essential for the developmental plasticity of the embryo, a function that might be widely conserved among other organisms.
Vasa is expressed in multiple cell lineages during development
Vasa is expressed throughout the egg and the early blastomeres of the sea urchin Strongylocentrotus purpuratus, and becomes enriched in the small micromere descendants that give rise to the germ line upon their formation (Voronina et al., 2008; Yajima and Wessel, 2011a). Vasa accumulation is expanded significantly to include the coelomic pouches, especially in the left side, where the adult rudiment is formed in the late larval stage (Fig. 1A,E; compare Vasa distribution of the left and right coelomic pouches between day-3 and day-5 larvae). Although a detailed lineage map of all cellular origins of the coelomic pouch is not yet known, contributions to this tissue come from small micromere and macromere descendants (e.g. Cameron et al., 1991) (Fig. 1F and Table 1). Additional contribution comes from the amniotic invagination of the ectoderm, which extends to and merges with the coelomic pouches to form an adult rudiment in the late larval stage (Fig. 1B-D, summarized in Fig. 1F and Table 1) (Cameron et al., 1987, 1991). The fidelity of Vasa labelling in this approach has been previously reported and includes use of the same controls and affinity-purified antibodies here (e.g. Voronina et al., 2008; Juliano and Wessel, 2009; and data not shown). At present, it is unknown what regulates Vasa expression in these late larvae, but recent work (Materna et al., 2013) suggests that the transcription factor FoxY controls the multipotency of coelomic pouch cells, and that, in turn, FoxY is activated by Delta/Notch signalling, beginning in the 16-cell stage.
To directly test here whether the expanded Vasa accumulation in the coelomic pouch is entirely derived from the small micromere lineage, several approaches were taken. First, the Vasa+ micromeres/small micromeres were surgically depleted at the 16- and 32-cell stages of L. variegatus embryos. This species was used only for this experiment because the embryo exhibits relatively little compensatory Vasa upregulation throughout the embryo compared with S. purpuratus (Voronina et al., 2008). This feature of the embryo makes for a more robust lineage conclusion, especially during the process of developmental recovery (referred to here as developmental re-programming). Following micromere and small-micromere removal, Vasa+ cells were not detected during early development in these embryos (Yajima and Wessel, 2011a). However, new Vasa+ cells reappeared in the coelomic pouches of the late feeding larvae (supplementary material Fig. S1A), similar to the original signal in wild-type larvae. This supports the conclusion of an additional, non-micromere lineage for this Vasa expression in the coelomic pouch. Next, we tested in S. purpuratus whether the macromere descendants (the tier of cells adjacent to the micromeres, thought to contribute to the coelomic pouch) became Vasa+ in normal embryos by injecting a reporter vasa-GFP mRNA (Gustafson et al., 2011) into fertilized eggs and a fluorescent dye into a single macromere of the 16-cell embryo (supplementary material Fig. S1B). The reporter Vasa-GFP approach is of high fidelity in reflecting endogenous Vasa expression, and it allows for longitudinal analysis of individual embryos (Gustafson et al., 2011). The macromere descendants and the Vasa-GFP+ cells did not overlap early in development (supplementary material Fig. S1B, day 3, arrows), but did so during larval development; ∼15% of the macromere descendants in the coelomic pouch expressed Vasa-GFP (supplementary material Fig. S1B, day 5, arrows). Previous studies documented a strict Vasa regulation by post-translational degradation – vasa mRNA is ubiquitously present until gastrula stage and is translated in all cells of the early embryo and larva, but is degraded rapidly in all cells except the germ cells (Gustafson et al., 2011; Yajima and Wessel, 2011b). Thus, the accumulation of Vasa in macromere descendants in the larva, which were previously Vasa-less cells, demonstrated a definitive somatic and post-transcriptional regulation of Vasa, consistent with the presence and dynamics of endogenous Vasa (Fig. 1; supplementary material Fig. S2).
High levels of Vasa accumulation continued during pouch development and throughout the adult rudiment (supplementary material Fig. S2A-E), together with lower amounts in the mouth and intestine of the larva. These tissues were also labelled by the affinity-purified anti-Vasa antibody (Voronina et al., 2008) and demonstrated a non-germline lineage for Vasa expression. The functional contributions of Vasa in those tissues are unclear, yet, considering that the left coelomic pouch originally consisted of about ten cells (Cameron et al., 1987, 1991), the amount of cell proliferation and Vasa expression in the adult rudiment is significant. Interestingly, these pouch cells also expressed seawi (a piwi orthologue in the sea urchin) and the positive cell cycle regulator cyclinB (supplementary material Fig. S2F-J). Further, these Vasa+ cells have higher BrdU incorporation (DNA synthesis during the cell cycle; see supplementary material Fig. S3A) than Vasa-null cells, suggesting a proliferative state of the Vasa+ somatic cells in the adult rudiment. It should be noted that cells in the mouth and intestine also showed strong BrdU incorporation and is consistent with the link between Vasa expression and the proliferative state of the cells. We conclude that Vasa expression is broad, often transient, in multiple, independent cell lineages from each germ layer, and is associated with increased cell proliferation.
Vasa functions in developmental re-programming and in wound healing
We hypothesized that Vasa might function in increased cellular proliferation, and we designed an experimental protocol to induce rapid cell cycling in otherwise slowly dividing cells to test this hypothesis. Cells in the arms of one-week-old control larvae demonstrate slow cell cycling and near-background levels of Vasa accumulation. However, when we induced physical damage with a glass needle in this quiescent tissue (Fig. 2A) and then pulse-treated with BrdU, we noted an increase in BrdU+ cells throughout the affected areas (Fig. 2B). The density of BrdU+ cells increased ∼twofold in the area of injury compared with the same area of uninjured larvae (Fig. 2C), or in non-injured arms of the experimental animals. This suggests a rapid induction of cell proliferation during wound healing in response to the damage. Interestingly, when these BrdU-labelled larvae were tested with the affinity-purified anti-Vasa antibody, endogenous Vasa expression was readily detected in the BrdU+ regions of the damaged larvae (Fig. 2D), but not in similar areas of normal larvae, or in uninjured arms of the damaged larva. Thus, Vasa accumulation is induced to increase rapidly and substantially in cells induced to proliferate.
To test Vasa induction in wound healing with a second approach, S. purpuratus day-5 larvae containing vasa-GFP mRNA were laser-bleached to damage a subset of larval tissues that do not normally accumulate Vasa protein. Membrane-mCherry mRNA was introduced with Vasa-GFP mRNA to visualize outlines of the cells and to normalize the Vasa-GFP signal in those larvae before and after damage. We detected a ∼four- to fivefold increase in Vasa-GFP signal (normalized to membrane-mCherry signal in the same region) in the damaged area (supplementary material Fig. S3B). In this experiment, mRNA (not a transgene) was injected into fertilized eggs, where it spread equally among the progeny, so any Vasa-GFP expression in this experiment was the consequence of post-transcriptional regulation of Vasa-GFP mRNA. Currently, we do not know whether this increase in Vasa signal is a result of increased translation of Vasa, a decrease in Vasa degradation (from a constitutive Vasa translation, as it occurs in the early embryo), or both. It is likely that many new genes were activated for wound healing, potentially including the cyclins and other genes involved in cell proliferation, but what is significant here is that Vasa protein is induced to accumulate coincidently with an increase in cellular proliferation.
To explore Vasa induction further, one half of a S. purpuratus larva was damaged, and we found that endogenous Vasa accumulation increased over fourfold compared with that of controls (supplementary material Fig. S4A,B). Only a slight increase was observed in mRNA expression by quantitative RT-PCR, and some expansion in spatial expression of Vasa was detected by in situ hybridization (supplementary material Fig. S4C,D). We conclude that Vasa protein overexpression is induced in response to tissue damage and occurs primarily post-transcriptionally. This increase is correlated with rapid cell cycling and in damage response of the normally Vasa-less somatic cells.
Next, we functionally tested the contribution of Vasa protein in the wound-healing process. Vasa was knocked down by morpholino antisense oligonucleotide (MO) treatment (supplementary material Fig. S4E). In larvae, vasa mRNA was present at near background levels throughout the entire embryo but was enriched in the small micromere lineage (Voronina et al., 2008). One half of an S. purpuratus embryo (day 1.5, blastula stage) was damaged by a glass needle during this experiment. Normal embryos that were damaged (normal, Fig. 3A,B) quickly healed their epithelium within 15 min-2 h, recovered swimming phenotypes, and most (80%) of the embryos gastrulated successfully within 20 h of damage. Embryos diminished in Vasa were still capable of development, although they lacked the enriched germline Vasa. However, damaged embryos lacking Vasa (Vasa-MO, Fig. 3A,B) were much less capable of repair and recovery; these embryos exhibited significant delays in ectodermal closure, they never resumed swimming or gastrulation and, eventually, they ceased development.
To test the effect of a different developmental stress, we removed micromeres, the major organizer of the embryo, from Vasa-deficient S. purpuratus embryos and tested the recovery of the germ line (Fig. 3C) (Yajima and Wessel, 2011a). The resultant embryos were, however, never capable of reaching gastrulation and instead died within 3-4 days after fertilization. On the contrary, Vasa-deficient embryos with micromeres, or embryos lacking micromeres but containing Vasa protein, successfully developed and gastrulated (albeit with some initial delay in development). These results suggest that Vasa is essential for developmental re-programming of the embryo and for wound healing.
Vasa is essential for protein synthesis in the early embryo
We tested the function of Vasa in early embryos and found that Vasa is essential for both reporter (injected mRNAs) and endogenous protein synthesis (Fig. 4A-E). Vasa-GFP mRNA (green) was injected into S. purpuratus fertilized eggs, and the Vasa-MO (experimental) or the Nanos2-MO (Nanos2 is another germline marker and used here as a specificity control; see Juliano et al., 2010) was injected into one of the two sibling blastomeres (co-injected with Red Dextran to follow the cell lineage) at the 2-cell stage. The injected embryos were then cultured until the 16- to 32-cell stage (prior to Nanos2 expression) and analysed for both developmental progression as well as expression of the GFP reporter. Injection of Vasa-MO (0.5 mM stock) into one of the 2-cell stage blastomeres resulted in a delay in cell cycle progression in the lineage containing the Vasa-MO (Fig. 4B, Vasa-MO only, arrow) (see Yajima and Wessel, 2011b for the detailed phenotype), but not in the sibling lineage. However, when Vasa-GFP (lacking the MO-site) was first injected into the egg, and subsequently the Vasa-MO (recognizing the endogenous but not the reporter Vasa) was injected into one of the 2-cell stage blastomeres, the Vasa-MO-containing blastomere was significantly rescued in development. They succeeded in the asymmetric cellular divisions at the 16-cell stage, even though Vasa-GFP synthesis was reduced by ∼30% compared with the control due to a general reduction of translation in those cells (Fig. 4C). Vasa-MO injected lineages showed a similar reduction in Vasa-GFP as well as Ne-GFP (eGFP with a nuclear localization signal) fluorescence, whereas Nanos2-MO-injected cells showed no reduction in the GFP signal (Fig. 4D,E). Although Vasa might have an additional, direct function in cell cycle regulation, these results suggest that Vasa controls cell cycle progression at least partly by regulation of general protein synthesis.
We then tested more generally which protein synthesis is dependent on Vasa function. To address this issue, we incorporated radioactively labelled amino acids into the analysis to identify Vasa-dependent protein synthesis. We injected S. purpuratus fertilized eggs with the Vasa-MO (1 mM stock) and then incubated the resultant embryos with 35S-methionine for 2.5 h from the 2- to 16-cell stage. Alongside this test, other cohorts of sibling embryos were treated with roscovitine or were untreated. Roscovitine was selected here as a comparison, as it is a cell cycle inhibitor (inhibiting cdk1, 2 and 5 with greatest specificity). As we anticipate that Vasa depletion will result in reduced cell cycling, we wanted to compare levels of protein synthesis in cells blocked from cycling and to distinguish these effects from any Vasa effects independent of cell cycling. Following the incubation period, the same number of embryos from each sibling cohort was split for measuring overall radioactive incorporation, both by TCA precipitation, and by PAGE separation followed by autoradiography. In both types of analysis, Vasa-depleted embryos showed significantly less overall protein synthesis (<20%) relative to both the control cohort and to the roscovitine-treated embryos (Fig. 4F). Although roscovitine treatment inhibited cell cycle progression (data not shown), the amount of overall protein synthesis in these embryos was not significantly different from control embryos (∼10% reduction). Thus, cell cycle inhibition did not adversely affect general protein synthesis. Importantly, PAGE analysis of newly synthesized proteins showed that Vasa functions broadly in protein synthesis – of the large numbers of distinct 35S-methionine-labelled proteins detected in control embryos, they were each uniformly decreased in intensity in embryos lacking Vasa (Fig. 4F). This is consistent with the results from TCA precipitation measuring total amino acid incorporation. Thus, Vasa appears to be involved in general protein synthesis in these early embryos, including both the wide population of native proteins as well as exogenously constructed proteins not normally present in these embryos.
Vasa appears to be essential for broad translational regulation, yet it is formally possible that Vasa only interacts with a very limited set of RNAs that encode key translational regulators. Absence of Vasa then might limit translation of this key factor(s) and the whole of translation might then be halted. To determine how broadly the population of mRNA is that interacts with Vasa, we performed Vasa-RIP (immunoprecipitation of RNA associated with Vasa) at 4- to 8-cell or 8-cell stage of S. purpuratus embryos. We extracted the mRNA that co-immunoprecipitated with Vasa, and compared it with control RIP results that included specific antibodies to eIF4E and Nanos2 (supplementary material Fig. S5A,B): eIF4E is a general translational regulator by functioning as the 7-methyl-guanosine cap-binding protein of mRNAs and serves as a positive control for broad mRNA association [reviewed by Topisirovic et al. (2011)]. Nanos2, on the other hand, interacts with specific mRNAs through the pumilio response element [reviewed by Saga (2010)] and is rare in embryos of this developmental stage (Juliano et al., 2006, 2010). Thus, it serves as an immune, negative control to complement the Vasa-pre-immune IgG control. The results show that pull-outs of Vasa and eIF4E contained a larger amount of RNAs compared with the Nanos2 or pre-immune IgG (supplementary material Fig. S5B), and RIP-qPCR results suggest that Vasa interacts with broad mRNA species at a similar level to eIF4E. This result suggests that Vasa functions by interacting with many different mRNAs for regulation of their translation, and not by a hierarchical interaction that indirectly affects translation more broadly (supplementary material Fig. S5C). From these results, we conclude that Vasa functions as a general translational regulator in these embryonic cells.
Vasa is specifically enriched in perinuclear granules during S phase and on the spindle during M phase (Yajima and Wessel, 2011b,c), and we hypothesized that Vasa might interact with a variety of mRNAs in these locations and function in efficient translation and/or distribution of mRNAs to the daughter cells in these large (relative to subsequent size of progeny; ∼100 μm diameter in first cell division and ∼10 μm in blastulae), rapidly dividing cells. We tested this hypothesis by visualizing various mRNA localizations by in situ hybridization (Fig. 5A; supplementary material Fig. S6A) and in live embryos (Fig. 5B; supplementary material Fig. S6B, Movie 1). Some mRNAs were discovered to be localized around the chromosomes during M phase and in perinuclear sites during S phase, very similar to the Vasa profile. This characteristic mRNA localization, however, was absent in Vasa-deficient embryos (Fig. 5A,B, Vasa-MO). Further, the human Histone 2B (H2B) mRNA, an exogenous reporter but known to be translated and localized in the nucleus of these embryonic cells (Yajima and Wessel, 2011b), showed no characteristic mRNA localization, yet did express GFP successfully in the nucleus (Fig. 5B; supplementary material Fig. S6B, Movie 2), suggesting that not all mRNAs interact equally with Vasa. Vasa in this embryo might thus interact with a pool of mRNAs by a selection mechanism that remains unclear. The selection for this Vasa-based broad mRNA interaction might be an increased translational efficiency, especially important in a large cell (∼100 μm diameter) that becomes rapidly dividing (lacking G phases), and is enhanced by translation locally using this mechanism during mitosis.
Vasa clusters mRNAs in an Importin-dependent manner during cell cycle progression
Using the Interactome database (Havugimana et al., 2012; Wan et al., 2013) (personal communications with Prof. Kathy Foltz at the University of California, San Diego; unpublished database), we identified Importin α2 (Kpna2) as a potential binding partner of Vasa. Importin α/β are known to form heterodimers and to target various proteins to the nuclear pore to shuttle them between the nucleus and the cytoplasm during S phase, as well as being required in formation of the spindle gradient during M phase (Goldfarb et al., 2004; Strom and Weis, 2001; Harel and Forbes, 2004). In the sea urchin embryo, Kpna2 did indeed localize similarly to Vasa in perinuclear regions during the S phase and on spindles during the M phase (Fig. 6A). Kpna2 immunoprecipitation (Kpna2-IP) pulled out Vasa (Fig. 6B) as well as Kpna2 itself, suggesting a physical interaction between Kpna2 and Vasa. Importazole (Soderholm et al., 2011), a specific functional inhibitor of Importin β, a partner of Kpna2, diminished the characteristic vasa mRNA and Vasa protein distribution, as well as other mRNA enrichment, both on the nuclear envelope and on the spindle (Fig. 6C, Importazole-Vasa IF; supplementary material Fig. S6A). Vasa-depletion, however, altered little of the Kpna2 localization either perinuclearly or on the spindle (Fig. 6A). Further, treatment of embryos with taxol, a microtubule stabilizer, resulted in excess Vasa protein and mRNA accumulation around the microtubules, implying that Vasa responded to microtubule arrays during the cell cycle (Fig. 6C, taxol-Vasa IF and -vasa ISH). These results suggest that Vasa depends on the cell ubiquitous Importin complex function for its positioning onto microtubules during somatic cell cycling.
The C-terminal proportion of Vasa (633-766aa of S. purpuratus Vasa) is responsible for both its specific localization and function in cell cycle progression (Gustafson et al., 2011; Yajima and Wessel, 2011b) and is important for its translational activity in Drosophila (617aa of D. melanogaster Vasa) (Liu et al., 2009). We found that Vasa lacking the C-terminus failed to recover the mRNA clustering activity in Vasa-deficient embryos (Fig. 6D, Vasa-C-term deletion), whereas a full-length Vasa successfully rescued a granular distribution of mRNAs (Fig. 6D, Vasa-full length), suggesting the Vasa C-terminus is important for multiple functions of Vasa, including its mRNA clustering activities. Currently, we do not know the mechanisms of mRNA clustering, but this phenotype of the molecule appears to be an important metric for its functionality in the germline and in somatic cells.
Vasa expression has long been used as a germline marker. It is, however, apparent, when looking outside some of the most intensively studied organisms, such as flies, worms, mice and fish, that many animals stray from this original paradigm. Indeed, the more broadly investigators examine non-traditional model organisms, the more diverse the original ‘germline factors’ become in cell expression and function. Further, these factors also appear to have multiple functions within a cell. For Vasa specifically, this includes recently documented functions recruited to the mitotic spindle both in the germ line and in somatic lineages (Rouhana et al., 2010; Lerit and Gavis, 2011; Pek and Kai, 2011; Yajima and Wessel, 2011b,c; Wagner et al., 2012).
We previously hypothesized that an ancient character of Vasa-like DEAD-box protein might have been in regulation of a rapid cell cycling in a large cell (Yajima and Wessel, 2011b,c), and the results in the present study provide mechanistic insight into this process. Even though Vasa has long been known and observed in many different organisms, it is rare to see Vasa expressed as dynamically as in sea urchins. Perhaps this reflects a vast regulative and regenerative capability of this embryo and adult. In addition, Vasa-expressing cells are more highly proliferative cells relative to their neighbours or sibling Vasa-null cells. The exception to this rule is the germ line (small-micromere lineage in the sea urchin), which enriches Vasa the most but has the slowest cell cycle in the embryo (Pehrson and Cohen, 1986; Tanaka and Dan, 1990). In the small micromeres, however, the cell-cycle suppressor Nanos is also expressed, probably as a dominant game changer in cell cycling activity (Juliano et al., 2010). Cell cycling in the early sea urchin embryo is rapid (20 min for M phase, 20 min for S phase and no G phase) and the cells are large, beginning at ∼100 μm in diameter, compared with cells in the differentiated tissues of the sea urchin. In those cells, Vasa might function in enhancing mRNA positioning for proper distribution and efficient translation, not just during S phase but also during M phase, to enhance rapid cell cycle progression (Blower et al., 2007) (Fig. 7). The conundrum for the field, however, is that Vasa appears to be essential in cells that express Vasa. As not all cells have Vasa, and yet function perfectly well, it is not clear what must be different in Vasa-expressing cells.
Here, we demonstrated that Vasa is essential for several developmental events, including reprogramming of cells in the embryos, wound healing of larval tissues and translational activity. The detailed mechanism of damage recovery followed by regeneration in this organism is still poorly understood, yet echinoderm regeneration appears to share many features with e.g. planarian regeneration. These animals are capable of regenerating most of their tissues, including gonads, and are regulated not by lineage-restricted unipotent stem cells but rather by pluripotent stem cells (Guo et al., 2006; Wagner et al., 2011). In the planarian, many germline-related genes, such as nanos, spoltud-1, smedwi-1, smedwi-2, bruno-like and pumilio, have been demonstrated to be involved in the regeneration process and the regenerative process dependent upon pluripotent stem cells, the neoblasts (Wang et al., 2007; Solana et al., 2009; Fernandez-Taboada et al., 2010; Scimone et al., 2010; Aboobaker, 2011). The expression of a Vasa-related DEAD-box protein, PL10, was reported to reside in the neoblasts (Shibata et al., 1999). More recently, genes encoding Vasa have been reported to be required for regeneration (Rouhana et al., 2010) or for proliferation of neoblast descendants (Wagner et al., 2012), thus implying Vasa's functionality in regeneration along with other germline-related genes expressed in neoblasts. The results herein then might indicate the mechanism of how the neoblasts make use of Vasa for its essential roles in regeneration, and how broadly Vasa functions in regenerative activities.
In summary, we conclude that Vasa has retained an ancient role as a multipotent cell regulator more effectively in sea urchins, presumably controlling mRNA translocation and translation of regulators for rapid and efficient embryogenesis. Vasa expression in the non-germ-cell lineage has been reported also in embryos of other organisms, such as of annelids and chaetognaths (Oyama and Shimizu, 2007; Carré et al., 2002), supporting this hypothesis. Additionally, a recent report involving spider development (Schwager et al., 2014) further supports the hypothesis of the role of Vasa in mitotic cell cycle progression in embryonic multipotent cells. We cannot rule out additional Vasa function in regulating piRNA production, as recently reported in flies (Xiol et al., 2014). The sea urchin embryo does have a large population of both miRNAs and piRNAs (Song et al., 2012), yet the phenotypes of Piwi, Drosha or Dicer knockdowns do not show a similar phenotype as the Vasa knockdown demonstrated in this report (Song et al., 2012; Yajima et al., 2014). Therefore, the somatic function of Vasa seen in the sea urchin might be independent of the piRNA (or miRNA) pathways, at least for the phenotypes seen herein. This is the first report that gives a mechanistic insight into Vasa function in somatic cell lineages, which is probably a conserved and fundamental function of this enigmatic molecule among organisms.
MATERIALS AND METHODS
Strongylocentrotus purpuratus were collected in Long Beach, California, USA (Point Loma Marine Invertebrate Lab), and Lytechinus variegatus were from Florida, USA (KP Aquatics). Handling, culture and gamete procurement followed standard protocol (Ettensohn et al., 2004). Larvae were cultured and fed on Chaetoceros gracilis (UTEX), as previously described (Yajima, 2007). Immunolabelling was conducted as previously described (Yajima and Kiyomoto, 2006; Voronina et al., 2008). Anti-SpVasa (Voronina et al., 2008), anti-KPNA2 antibody (Novus Biologicals, NB100-79807; 1.0 mg/ml stock) and anti-BrdU monoclonal antibody (Sigma, #B2531) were used at final concentrations of 1:300, 1:500 and 1:200, respectively. The secondary antibodies conjugated to Cy3, Alexa 488 or Alexa 594 (all by Invitrogen) were used at final concentrations of 1:250, 1:500 and 1:500, respectively. Embryo manipulations and imaging were performed as described previously (Yajima, 2007; Yajima and Wessel, 2011a), and Vasa-GFP protocols were previously described by Gustafson et al. (2011) and Yajima and Wessel (2011b, 2012). This protocol was confirmed to replicate the endogenous Vasa expression and to rescue the cell-cycle defects in Vasa-MO-injected embryos (Gustafson et al., 2011). Ne-GFP and H2B (Histone2B)-EGFP were gifts from Dr Yasunori Sasakura at Tsukuba University, Japan, and from Dr Sean Megason at Harvard University, USA (GenBankFiles\p005_pCS-H2B-EGFP.gb), respectively. The specificity and controls for the Sp-vasa morpholino (Vasa-MO) was previously documented (Gustafson et al., 2011; Yajima and Wessel, 2011b). Labelling of mRNA and injection were performed as described (Gagnon and Mowry, 2011), using Alexa 546-UTP in the SP6 mMessage mMachine (Ambion) protocol. Quantitative RT-PCR was performed as described (Juliano et al., 2006), using PCR primers listed in the supplementary material Table S1. The protocol for in situ RNA hybridization was as described (Arenas-Mena et al., 2000; Yajima et al., 2013). Protein synthesis was determined using 35S-methionine (200 μCi) incorporation and roscovitine was used at a final concentration of 0.1 μM. The immunoprecipitation protocol (IP) is documented in the supplementary materials methods. Antibodies used for the IP procedure were affinity-purified anti-Vasa (Voronina et al., 2008), anti-KPNA2 antibody (Novus Biologicals, NB100-79807; 1.0 mg/ml stock) and YP30 (Wessel et al., 2000). Inhibitors used in embryo treatment included 100 μM importazole (Sigma, SML0341) or 100 μM taxol (Sigma, Paclitaxel-T7402). Please see the supplementary materials methods for a full description of materials and methods.
We thank Professor Kathy Foltz at UCSB (firstname.lastname@example.org) for sharing a list of Vasa-interactors from their Interactome database and members of PRIMO for critical discussions and support.
This work was supported by the National Institutes of Health [2R01HD028152] and the National Science Foundation [IOS-1120972] grants to G.M.W.; and by the American Heart Association Scientist Development Grant [14SDG18350021] and a Human Frontier Science Program long-term fellowship to M.Y. Deposited in PMC for release after 12 months.
M.Y. was responsible for concepts, experimental design and undertaking, data analysis, manuscript construction and editing; G.M.W. was responsible for conceptualization, experimental design, manuscript construction and editing.
The authors declare no competing or financial interests.